Relief Therapeutics and NeuroRx Announce Enrollment of First Patients with RLF-100 in Phase 2b/3 Clinical Trial in Patients with ...
First participants treated at the University of Miami Miller School of Medicine with intravenous RLF-100 Clinical trial to enroll 144 patients total with expansion to additional sites including the University of California, Irvine and Thomas Jefferson …